MPMegan E. Paulsen

Megan E. Paulsen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Megan E. Paulsen has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Debra Kulhanek

    Division of Neonatology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota

    2 shared publications
  • Debra R. Kulhanek

    Department of Pediatrics, Division of Neonatology, University of Minnesota Medical School, Minneapolis, MN 55454, USA

    2 shared publications
  • Juan David Gonzalez Villamizar

    Division of Neonatology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, USA

    2 shared publications
  • Nicholas Marka

    Biostatistical Design and Analysis Center, Clinical Translational Science Institute, University of Minnesota, Minneapolis, USA

    2 shared publications
  • Raghavendra B. Rao

    Department of Pediatrics, Center for Neurobehavioral Development, University of Minnesota Medical School, Minneapolis, MN

    2 shared publications
  • Raghavendra Rao

    Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA

    2 shared publications

Latest Publications

  • Open Access

    Implementation of perinatal mental health screening for parents of infants in a level IV neonatal intensive care unit: A quality improvement initiative

    by Sarah A. Swenson, Megan E. Paulsen, Kelsey Carrigan, Rachael Stover-Haney, Delaney Wilton, Brittney Skalland, Andrea L. Lampland, Ellen Diego, Maria Kroupina, Erin A. Osterholm, et al.

    Objective: We aimed to establish standardized perinatal mental health (PMH) screening performed by social workers for parents in the neonatal intensive care unit (NICU) at 1, 2, 4, and 6 months, increasing screening rates from 0% to 70% within 6 months. Study design: Baseline data evaluated informal PMH assessments. Primary measure was percent of parents screened and was monitored by statistical process control charts. Process measures were percent of parents with scores above threshold for referral for further evaluation and/or treatment, appropriately referred, and declining screening. Balancing measures were negative perceptions of screening. Results: The centerline for screening rate was 80% for mothers and 72% for partners. Screening increased concerns detected beyond 1 month from 12 to 60. Concerns representing partners increased from 3/52 (6%) to 18/60 (30%). Conclusion: Standardized NICU PMH screening improved identification of PMH concerns beyond the first weeks of admission for both mothers and partners.


  • Open Access

    Inflammation as a Sex-Specific Mediator in the Relationship between Maternal and Offspring Obesity in C57Bl/6J Mice

    by Lauren A. Buckley, Debra R. Kulhanek, Adrienne Bruder, Tate Gisslen, Megan E. Paulsen

    Maternal obesity is a well-established risk factor for offspring obesity development. The relationship between maternal and offspring obesity is mediated in part by developmental programming of offspring metabolic circuitry, including hypothalamic signaling. Dysregulated hypothalamic inflammation has also been linked to development of obesity. We utilized an established C57Bl/6J mouse model of high-fat, high-sugar diet induced maternal obesity to evaluate the effect of maternal obesity on systemic and hypothalamic TNF-α, IL-6, and IL-1β levels in neonatal and adult offspring. The offspring of dams with obesity demonstrated increased adiposity and decreased activity compared to control offspring. Maternal obesity was associated with decreased plasma TNF-α, IL-6 and IL-1β in adult female offspring and decreased plasma IL-6 in neonatal male offspring. Neonatal female offspring of obese dams had decreased TNF-α gene expression in the hypothalamus compared to control females, while neonatal and adult male offspring of obese dams had decreased IL-6 gene expression in the hypothalamus compared to control males. In summary, our results highlight important sex differences in the inflammatory phenotype of offspring exposed to maternal obesity. Sex-specific immunomodulatory mechanisms should be considered in future efforts to develop therapeutic interventions for obesity prevention and treatment.


  • Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 as early predictors of growth, body composition, and neurodevelopment in preterm infants

    by Megan E. Paulsen, Nicholas Marka, Scott Lunos, Emily M. Nagel, Juan David Gonzalez Villamizar, Brandon Nathan, Sara Ramel

    Objective To investigate the relationship between insulin-like growth factor 1 (IGF-1), insulin-like growth factor binding protein 3 (IGFBP-3) and long-term growth, body composition, and neurodevelopment in preterm infants. Study design Prospective data were collected from ≤32 weeks gestational age infant cohort (N = 50). IGF-1 and IGFBP-3 concentrations were measured at 1 week (early) and 35 weeks (late) post-menstrual age (PMA). Growth, body composition, and neurodevelopment outcomes were measured at 4 and 12 months PMA. Relationships were measured by linear regression analysis. Results Early IGFBP-3 concentration was positively associated with neurodevelopment at 12 months PMA. Early IGF-1 concentration was positively associated with weight at 4 months PMA, head circumference at 12 months PMA, and body mass index at 12 months PMA. Late IGFBP-3 concentration was positively associated with weight at 4 months PMA. Conclusion Further investigation of these associations may lead to novel biomarkers and/or treatments to optimize health outcomes in preterm infants.


  • An exploratory study of clinical factors associated with IGF-1 and IGFBP-3 in preterm infants

    by Megan E. Paulsen, Nicholas Marka, Emily M. Nagel, Juan David Gonzalez Villamizar, Brandon M. Nathan, Sara E. Ramel

    Background Despite advances in parenteral nutrition, postnatal growth failure in very low birthweight (VLBW) preterm infants is common and associated with chronic health problems. Insulin-like growth factor 1 (IGF-1) is positively associated with improved infant growth, but factors which promote IGF-1 levels in this population have not been clearly identified. The objective of this study was to explore early factors that influence IGF-1 in VLBW preterm infants. Methods VLBW infants were enrolled into a prospective, randomized controlled nutrition trial (N = 87). Outcome measures included IGF-1 and IGFBP-3 levels measured at 35 weeks PMA. Linear regression analyses tested the relationships between candidate clinical predictors and levels of IGF-1 and IGFBP-3. Results Higher protein intake, longer duration of parenteral nutrition, and lower IGFBP-3 levels at 1 week of life were associated with lower IGF-1 levels at 35 weeks PMA. Neither early markers of insulin resistance nor degree of illness were associated with IGF-1 levels at 35 weeks PMA. Conclusion Optimization of early nutrient intake, and attention to route of delivery, may have a lasting influence on IGF-1/IGFBP-3, and in turn, long-term health outcomes. Impact In very low birthweight preterm infants, early protein intake, duration of parenteral nutrition, and insulin-like growth factor binding protein 3 (IGFBP-3) levels at 1 week of life are positively associated with insulin-like growth factor 1 (IGF-1) levels at 35 weeks postmenstrual age. Data from this study highlight the influence of early nutrition on components of the endocrine axis in preterm infants. Strategies aimed at early initiation of enteral nutrition, as well as optimizing composition of parenteral nutrition, may bolster hormones involved in promoting preterm infant growth.


  • Female and male C57BL/6J offspring exposed to maternal obesogenic diet develop altered hypothalamic energy metabolism in adulthood

    by Debra Kulhanek, Juan E. Abrahante Llorens, Lauren Buckley, Ivan Tkac, Raghavendra Rao, Megan E. Paulsen

    Offspring exposed to maternal diet-induced obesity demonstrate a phenotype consistent with energy excess. Contrary to previous studies, the observed energy phenotype was not associated with hyperphagia or decreased basal metabolic rate but rather decreased hypothalamic neuronal activity and energy production. This was supported by neurochemical changes in the hypothalamus as well as inhibition of hypothalamic oxidative phosphorylation pathway. These results highlight the potential for neuroprotective interventions in the prevention of obesity with fetal origins.


  • Cerebral Effects of Neonatal Dysglycemia

    by Megan E. Paulsen, Raghavendra B. Rao


  • Protecting the infant-parent relationship: special emphasis on perinatal mood and anxiety disorder screening and treatment in neonatal intensive care unit parents

    by Julie Johnson Rolfes, Megan Paulsen

    Perinatal mood and anxiety disorders (PMADs) are common, particularly among parents of infants requiring admission to the neonatal intensive care unit (NICU), yet remain underdiagnosed and undertreated. Undertreated parental mental health disorders can interfere with healthy infant development, compounding abnormal neurodevelopment and psychosocial development that preterm or ill newborns may already face. Interdisciplinary efforts to increase PMAD awareness, screening, and referral uptake may improve family-infant health and developmental outcomes in high-risk infants requiring NICU admission. Therefore, special emphasis on PMAD screening and treatment in NICU parents aligns with the American Academy of Pediatrics mission and should be a focus in neonatal care and included in education, quality improvement, and outcome-based research initiatives.


  • Long-Term Outcomes after Early Neonatal Hyperglycemia in VLBW Infants: A Systematic Review

    by Megan E. Paulsen, Sarah Jane Brown, Katherine M. Satrom, Johannah M. Scheurer, Sara E. Ramel, Raghavendra B. Rao

    Introduction: Long-term effects of early hyperglycemia in VLBW infants are poorly characterized. The objective of this study was to systematically review the effect of early hyperglycemia on growth, metabolic health, and neurodevelopment after neonatal intensive care unit discharge in VLBW infants. Methods: The systematic review was conducted in accordance with the PRISMA guidelines. A study protocol was registered in PROSPERO (CRD42019123335). Data sources included Ovid MEDLINE, Embase, Cochrane Library, CINAHL, and Scopus. Selected studies included infants with a blood glucose concentration >150 mg/dL (8.3 mmol/L) during the first 28 days of life, a gestational age (GA) Results: Eight studies (n = 987 infants) reported long-term outcomes from 4-month corrected GA to 7 years old. Most studies compared long-term outcomes of preterm infants with and without hyperglycemia. Two studies addressed outcomes related to interventions following early hyperglycemia. Some studies found differences in growth, metabolic health, and neurodevelopment outcomes between VLBW preterm infants with hyperglycemia and without hyperglycemia, while other studies found no differences between groups. The overall graded quality of evidence was low. Conclusions: Well-designed randomized controlled and prospective studies are necessary to determine the effect of early hyperglycemia and its treatment on later metabolic and neurodevelopmental outcomes in VLBW infants. Authors propose a potential study design for standardizing the assessment of long-term metabolic and neurodevelopmental outcomes following early hyperglycemia in preterm infants.


  • Open Access

    Excess sucrose intake during pregnancy programs fetal brain glucocorticoid receptor expression in female but not male C57Bl/6J mice

    by Debra Kulhanek, Raghavendra B. Rao, Megan E. Paulsen

    Background: Sex‐specific mechanisms explaining the association between mothers with obesity and the development of obesity in children are poorly characterized. Permanent changes in fetal brain glucocorticoid receptor (GR) expression caused by exposure to overnutrition in utero may program aberrant energy homeostasis, thereby predisposing the offspring to obesity. This study explores sex differences in brain GR expression using an established mouse model of overnutrition during pregnancy.Methods: Female C57Bl/6J mice were fed control (CON) or high‐fat–high‐sucrose (HFHS) diets. Dam cholesterol, insulin, and triglycerides were measured by colorimetric assays. Fetal corticosterone exposure was measured by placental Abca1, Hsd11β1, Hsd11β2, and brain Nr3c1 (GR); Pomc expression measured by RT‐qPCR.Results: Female, but not male, HFHS fetuses had 46% decreased brain GR and twofold increased Pomc expression. There was decreased Abca1 and Hsd11β1 but not Hsd11β2 expression in HFHS placentas. Caloric and sucrose intake, but not fat intake, in dams inversely correlated with fetal GR expression in both sexes. Excess sucrose consumption by dams inversely correlated with female fetal GR and directly correlated with female fetal Pomc expression.Conclusions: Excess sucrose consumption in pregnant dams caused lower GR and higher Pomc expression in the female fetal brain. Clinical investigation of excess sucrose intake during pregnancy and its subsequent effect on hypothalamic‐pituitary‐adrenal axis activity and appetite in offspring may lead to novel, sex‐specific obesity prevention strategies in the development of obesity in children.


  • Open Access

    Maternal High-Fat–High-Carbohydrate Diet-Induced Obesity Is Associated with Increased Appetite in Peripubertal Male but Not Female C57Bl/6J Mice

    by Debra Kulhanek, Rachel Weigel, Megan E. Paulsen

    Diet-induced maternal obesity might play a critical role in altering hypothalamic development, predisposing the offspring to obesity and metabolic disease later in life. The objective of this study was to describe both phenotypic and molecular sex differences in peripubertal offspring energy homeostasis, using a mouse model of maternal obesity induced by a high-fat–high-carbohydrate (HFHC) diet. We report that males, not females, exposed to a maternal HFHC diet had increased energy intake. Males exposed to a maternal HFHC diet had a 15% increased meal size and a 46% increased frequency, compared to the control (CON) males, without a change in energy expenditure. CON and HFHC offspring did not differ in body weight, composition, or plasma metabolic profile. HFHC diet caused decreased hypothalamic glucocorticoid expression, which was further decreased in males compared to females. Maternal weight, maternal caloric intake, and male offspring meal frequency were inversely correlated with offspring hypothalamic insulin receptor (IR) expression. There was a significant interaction between maternal-diet exposure and sex in hypothalamic IR. Based on our preclinical data, we suggest that interventions focusing on normalizing maternal nutrition might be considered to attenuate nutritional influences on obesity programming and curb the continuing rise in obesity rates.